We asked the FA community to help design FARF’s 30th anniversary t-shirt. You all responded with some fantastic entries. We have narrowed down the submissions to six finalists, and now the voting turns to YOU. Please look at each of...
Announcements
We asked the FA community to help design FARF’s 30th anniversary t-shirt. You all responded with some fantastic entries. We have narrowed down the submissions to six finalists, and now the voting turns to YOU. Please look at each of...
Announcements
FA families started FA Day 10 years ago to raise funds for research & family support services. We know that longer and better lives for people with FA are possible when we all get involved. #ThisIsHowIFA reflects the many people it...
Announcements
To fast-track therapies for people with Fanconi anemia (FA), it’s often best to start by examining progress that’s already been made in the general population. Large-scale studies such as The Cancer Genome Atlas (TCGA) have made it possible to detect...
Announcements
An update for FA families In the March 2019 issue of Trends in Genetics, researchers from St. Vincent’s Institute in Australia published a paper on the FA pathway and fertility. We asked the authors to provide a summary for FA families....
Announcements
The global Fanconi anemia gene therapy program is now open in the USA and Europe. In Europe, a new study, known as FANCOLEN-2, is available at CIEMAT/Hospital del Niño Jesús in Madrid, Spain. In the USA, a similar study is now...
Announcements
People with Fanconi anemia (FA) have a 500- to 700-fold increased risk of developing head and neck squamous cell carcinoma (HNSCC) tumors when compared to the general population. Conventional treatments available for non-FA-HNSCC such as radiation therapy and chemotherapy are...
Announcements